A Pilot Trial of the Reach Out, Stay Strong, Essentials for Mothers of Newborns (ROSE) Postpartum Depression Prevention Intervention in Pregnant Patients Admitted to Strong Hospital
A Pilot Trial of the ROSE Postpartum Depression Prevention Intervention in Antepartum Patients Admitted to High-risk Obstetrics Unit
1 other identifier
interventional
45
1 country
1
Brief Summary
This study is a pilot, single-center, randomized controlled trial. It will
- 1.determine feasibility and acceptability of an evidence-based intervention for prevention of postpartum depression with antepartum patients on a high-risk obstetric unit,
- 2.determine what adaptations may be needed for an inpatient population
- 3.determine what retention strategies are most successful and acceptable for this patient population
- 4.estimate the effect size of an intervention for in-hospital distress, anxiety and depression
- 5.estimate the effect size of an intervention to reduce the risk of a post-partum depression diagnosis or depressive symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 5, 2021
CompletedFirst Submitted
Initial submission to the registry
January 7, 2022
CompletedFirst Posted
Study publicly available on registry
February 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 2, 2022
CompletedJune 13, 2022
June 1, 2022
10 months
January 7, 2022
June 9, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
Subject-reported in-hospital distress
Hospital distress will be measured using the Depression, Anxiety and Stress Scale-21 (DASS-21) Stress subscale. Stress subscale ranges from 0 to 42 with higher scores indicating worse outcome.
14 days
Subject-reported depressive symptom severity
Depressive symptom severity will be measured using the Edinburgh Postnatal Depression Scale (EPDS). The scale ranges from 0-30 with higher scores indicating worse outcome.
6 weeks postpartum
Subject-reported anxiety symptom severity
Anxiety symptom severity will be measured using the General Anxiety Disorder-7 (GAD-7) measurement scale. The scale ranges from 0 to 21 with higher scores indicating worse outcome.
6 weeks postpartum
Clinical diagnosis of depression
Diagnosis of depression will be made using the Mini International Neuropsychiatric Interview (M.I.N.I) brief structured diagnostic interview which explores, in a standardized way, the main psychiatric disorders of Axis I of the DSM-IV TR. Only modules A and B (Major depressive episode and dysthymia) will be used. This structured interview contains questions with binary answers, with Yes indicating worse outcome.
6 weeks postpartum
Other Outcomes (6)
satisfaction with ROSE behavioral health intervention
14 days and 6 weeks postpartum
self-reported mother-infant bonding
6 weeks postpartum
self-reported functional status
6 weeks postpartum
- +3 more other outcomes
Study Arms (2)
ROSE Intervention
EXPERIMENTALStandard of Care
ACTIVE COMPARATORInterventions
The ROSE (Reach Out, Stay Strong, Essentials for mothers of newborns) program is an evidence-based intervention that has been proven to reduce cases of post-partum depression among low-income and racially and ethnically diverse women. ROSE is administered to pregnant women in small group settings, typically in the same location that prenatal care is being provided (in this study, a hospital setting). It is divided into four 90-minute group sessions and teaches interpersonal psychotherapy-based skills that mitigate identified risk factors for PPD such as social support, stress management skills and communication. ROSE curriculum will be implemented using groups in a continuous cycle, with patients entering into the intervention curriculum at the time of their enrollment and continuing through until all 4 total sessions have been accomplished.
Eligibility Criteria
You may qualify if:
- Viable pregnancy between 20 weeks 0 days and 35 weeks 0 days gestation at the time of enrollment
- Anticipated admission to the hospital for \>5 days due to pregnancy complication requiring hospital observation
- Age \> 18 years
- Planned hospitalization at Strong Memorial Hospital through the duration of antepartum course
- Planned delivery at Strong Memorial Hospital
You may not qualify if:
- Fetal demise in utero
- Inability to give informed consent secondary to intellectual capacity
- English is not primary language used to communicate
- Currently incarcerated
- Age \< 18 years
- Planned antepartum hospitalization at another institution
- Planned delivery at another institution
- Actively suicidal or in need of acute psychiatric care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Rochesterlead
- Mae Stone Goode Foundationcollaborator
Study Sites (1)
Strong Hospital
Rochester, New York, 14642, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 7, 2022
First Posted
February 4, 2022
Study Start
July 5, 2021
Primary Completion
May 2, 2022
Study Completion
May 2, 2022
Last Updated
June 13, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share